Medtronic, Inc. (NYSE:MDT) ranks among the top stocks for an early retirement portfolio. On June 18, RBC Capital reiterated a ...

Medtronic has announced that its planned spinoff diabetes business will be named MiniMed, reviving the original name of the company acquired by Medtronic in 2001. The separation is expected to ...

Medtronic, a global leader in healthcare technology, will present data at the American Diabetes Association (ADA) 85th ...

The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001.

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

Medtronic's (NYSE:MDT) stand-alone diabetes company, first announced in May, will be known as MiniMed. MiniMed was the original name of the diabetes company Medtronic acquired in 2001.

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

The MiniMed 780G insulin pump system is a cost-effective treatment option in the US for type 1 diabetes vs multiple daily injections with intermittently scanned continuous glucose monitoring.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the ...

**MiniMed™ 780G system is for type 1 ages 7 and over. Prescription required. WARNING: Do not use SmartGuard™ feature for people who require less than 8 units or more than 250 units of insulin/day.

GALWAY, Ireland, June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following ...